Promise and challenges in the development of COVID-19 vaccines
W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …
unprecedented challenge to global public health system and biomedical community …
[HTML][HTML] Progress and challenges in the development of COVID-19 vaccines and current understanding of SARS-CoV-2-specific immune responses
KD Kim, I Hwang, KB Ku, S Lee, SJ Kim… - Journal of microbiology …, 2020 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared …
syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared …
An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era
A Pascual-Iglesias, J Canton, AM Ortega-Prieto… - Pathogens, 2021 - mdpi.com
The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic all over the
world. When the virus was first isolated and its genome was sequenced in the early months …
world. When the virus was first isolated and its genome was sequenced in the early months …
COVID-19 vaccines: current conditions and future prospects
T Zieneldien, J Kim, J Cao, C Cao - Biology, 2021 - mdpi.com
Simple Summary The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first encountered in …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first encountered in …
Coronavirus disease 2019 vaccine development: an overview
R Sumirtanurdin, MI Barliana - Viral immunology, 2021 - liebertpub.com
To this day, the coronavirus disease 2019 (COVID-19) pandemic has not shown signs of
abating. Moreover, the virus responsible for the pandemic, severe acute respiratory …
abating. Moreover, the virus responsible for the pandemic, severe acute respiratory …
COVID-19 vaccines: where did we stand at the end of 2023?
K Lundstrom - Viruses, 2024 - mdpi.com
Vaccine development against SARS-CoV-2 has been highly successful in slowing down the
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations
Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …
significantly higher than that of the first wave of early 2020. Many countries or regions have …
Viral targets for vaccines against COVID-19
L Dai, GF Gao - Nature Reviews Immunology, 2021 - nature.com
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19)
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …
SARS-CoV-2 vaccine candidates in rapid development
L Li, P Guo, X Zhang, Z Yu, W Zhang… - Human vaccines & …, 2021 - Taylor & Francis
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is still spreading globally. The scientific community is attempting to procure …
(SARS-CoV-2) is still spreading globally. The scientific community is attempting to procure …
SARS-CoV-2 vaccines—The biggest medical research project of the 21st century
D Kurup, MJ Schnell - Current Opinion in Virology, 2021 - Elsevier
SARS-CoV-2 has been detected in more than 141 million people and caused more than 3
million deaths worldwide. To reduce the additional loss of millions of lives until natural …
million deaths worldwide. To reduce the additional loss of millions of lives until natural …